Bellevue Asset Management, LLC Emergent Bio Solutions Inc. Transaction History

Bellevue Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$56.61 - $80.46 $2,490 - $3,540	-44 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$86.23 - $125.19 $431 - $625	-5 Reduced 10.2%	44 $4,000
Q4 2020 Feb 11, 2021	BUY	$79.17 - $111.47 $633 - $891	8 Added 19.51%	49 $5,000
Q1 2020 May 13, 2020	BUY	$49.34 - $68.76 $1,184 - $1,650	24 Added 141.18%	41 $3,000
Q4 2019 Feb 13, 2020	BUY	$51.21 - $59.06 $870 - $1,004	17 New	17 $1,000

158

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $561M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.